Effects of Anti-H. Pylori Triple Therapy and a Probiotic Complex on Intestinal Microbiota in Duodenal Ulcer

Overview

Journal Sci Rep

Specialty Science

Date 2019 Sep 8

PMID 31492912

Citations 17

Authors

Lili Wu

Zikai Wang

Gang Sun

Lihua Peng

Zhongsheng Lu

Bin Yan

Kun Huang

Yunsheng Yang

Affiliations

Soon will be listed here.

Abstract

This study aimed to investigate the intestinal microbiota in duodenal ulcer (DU) patients, effects of proton pump inhibitors,clarithromycin and amoxicillin, PCA) for Helicobacter pylori (H. pylori) and Bacillus subtilis and Enterococcus faecium (BSEF) on intestinal microbiota. DU patients were randomly assigned to receive either PCA (group TT) or PCA plus BSEF(group TP). The fecal microbiome was conducted using high throughput 16S rDNA gene and internal transcribed spacer sequencings. The diversity and abundance of intestinal bacteria in the DU were significantly lower than health check control (HC) group. In the TT group, the abundance and diversity of both intestinal bacteria and fungi decreased after PCA treatment, compared with those before treatment, whereas in the TP group no obvious changes were observed. In the TT group at all the time points, both the intestinal bacteria and fungi were different from those in the HC group. However, in the TP group, at 10w the bacterial flora abundance was close to that in the HC group. The results indicate that anti- H. pylori treatment induced significant decrease in the diversity of intestinal microbiota, while the combined therapy supplemented with BSEF could protect and restore the intestinal microbiota.

Citing Articles

Bibliometric and visualisation analyses of gastric ulcer knowledge areas and emerging trends, 2004-2024.

Liu Z, Liu Y, Li Y, Sun Y, Song X, Chen L Front Med (Lausanne). 2025; 12:1530835.

PMID: 40061369 PMC: 11885240. DOI: 10.3389/fmed.2025.1530835.

and gastric cancer: current insights and nanoparticle-based interventions.

Shah S, Mumtaz M, Sharif S, Mustafa I, Nayila I RSC Adv. 2025; 15(7):5558-5570.

PMID: 39967885 PMC: 11834156. DOI: 10.1039/d4ra07886a.

The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.

Zaman T, Haq A, Ahmad R, Sinha S, Chowdhury K, Parvin S Cureus. 2024; 16(3):e56283.

PMID: 38495972 PMC: 10944298. DOI: 10.7759/cureus.56283.

Helicobacter pylori and oral-gut microbiome: clinical implications.

Elghannam M, Hassanien M, Ameen Y, Turky E, ELattar G, ELRay A Infection. 2023; 52(2):289-300.

PMID: 37917397 PMC: 10954935. DOI: 10.1007/s15010-023-02115-7.

Crosstalk between and gastrointestinal microbiota in various gastroduodenal diseases-A systematic review.

Sharma P, Phatak S, Warikoo P, Mathur A, Mahant S, Das K 3 Biotech. 2023; 13(9):303.

PMID: 37588796 PMC: 10425313. DOI: 10.1007/s13205-023-03734-5.

References

Bartlett J . Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002; 346(5):334-9. DOI: 10.1056/NEJMcp011603. View

Kim M, Kim N, Lee S, Park Y, Hwang J, Kim J . The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter. 2008; 13(4):261-8. DOI: 10.1111/j.1523-5378.2008.00601.x. View

Duman D, Bor S, Ozutemiz O, Sahin T, Oguz D, Istan F . Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication. Eur J Gastroenterol Hepatol. 2005; 17(12):1357-61. DOI: 10.1097/00042737-200512000-00015. View

Chen X, Liu X, Tian F, Zhang Q, Zhang H, Zhang H . Antagonistic activities of lactobacilli against Helicobacter pylori growth and infection in human gastric epithelial cells. J Food Sci. 2011; 77(1):M9-14. DOI: 10.1111/j.1750-3841.2011.02498.x. View

De Luca L, Zagari R, Pozzato P, Fiorini T, Ricciardiello L, Martuzzi C . Measuring dyspepsia: a new severity index validated in Bologna. Dig Liver Dis. 2005; 36(12):806-10. DOI: 10.1016/j.dld.2004.07.010. View

Sheu B, Wu J, Lo C, Wu H, Chen J, Lin Y . Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2002; 16(9):1669-75. DOI: 10.1046/j.1365-2036.2002.01335.x. View

Jackson M, Goodrich J, Maxan M, Freedberg D, Abrams J, Poole A . Proton pump inhibitors alter the composition of the gut microbiota. Gut. 2016; 65(5):749-56. PMC: 4853574. DOI: 10.1136/gutjnl-2015-310861. View

Wang Q, Garrity G, Tiedje J, Cole J . Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007; 73(16):5261-7. PMC: 1950982. DOI: 10.1128/AEM.00062-07. View

Perez-Cobas A, Gosalbes M, Friedrichs A, Knecht H, Artacho A, Eismann K . Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2012; 62(11):1591-601. PMC: 3812899. DOI: 10.1136/gutjnl-2012-303184. View

10.

Blaser M . Antibiotic use and its consequences for the normal microbiome. Science. 2016; 352(6285):544-5. PMC: 4939477. DOI: 10.1126/science.aad9358. View

11.

Dai C, Zheng C, Jiang M . Efficacy of probiotics in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2013; 47(9):814-5. DOI: 10.1097/MCG.0b013e318298a32c. View

12.

Pinchuk I, Bressollier P, Verneuil B, Fenet B, Sorokulova I, Megraud F . In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics. Antimicrob Agents Chemother. 2001; 45(11):3156-61. PMC: 90797. DOI: 10.1128/AAC.45.11.3156-3161.2001. View

13.

Malfertheiner P, Megraud F, OMorain C, Atherton J, Axon A, Bazzoli F . Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012; 61(5):646-64. DOI: 10.1136/gutjnl-2012-302084. View

14.

GUERRE J, Vedel G, Gaudric M, Paul G, Cornuau J . [Bacterial flora in gastric juice taken at endoscopy in 93 normal subjects]. Pathol Biol (Paris). 1986; 34(1):57-60. View

15.

Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y . Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. J Gastroenterol. 2003; 38(4):339-47. DOI: 10.1007/s005350300061. View

16.

Kahrstrom C, Pariente N, Weiss U . Intestinal microbiota in health and disease. Nature. 2016; 535(7610):47. DOI: 10.1038/535047a. View

17.

Adamsson I, Nord C, Lundquist P, Sjostedt S, Edlund C . Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients. J Antimicrob Chemother. 1999; 44(5):629-40. DOI: 10.1093/jac/44.5.629. View

18.

Edgar R . UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat Methods. 2013; 10(10):996-8. DOI: 10.1038/nmeth.2604. View

19.

Tompkins T, Hagen K, Wallace T, Fillion-Forte V . Safety evaluation of two bacterial strains used in Asian probiotic products. Can J Microbiol. 2008; 54(5):391-400. DOI: 10.1139/w08-022. View

20.

Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V . The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther. 2001; 15(2):163-9. DOI: 10.1046/j.1365-2036.2001.00923.x. View